Carotenoids supplementation and inflammation: a systematic review and meta-analysis of randomized clinical trials

Hajizadeh-Sharafabad, Fatemeh and SharifiZahabi, Elham and Malekahmadi, Mahsa and Zarrin, Rasoul and Alizadeh, Mohammad Carotenoids supplementation and inflammation: a systematic review and meta-analysis of randomized clinical trials. Critical Reviews in Food Science and Nutrition.

Text 2606.pdf Download (3MB)

Abstract

The aim of this study was to perform a systematic review and meta-analysis on randomized controlled trials investigating the effects of carotenoids on selected inflammatory parameters. PubMed, SCOPUS, and Web of science were searched from inception until April 2021. The random- effect model was used to analyze data and the overall effect size was computed as weighted mean difference (WMD) and corresponding 95% of confidence interval (CI). A total of 26 trials with 35 effect sizes were included in this meta-analysis. The results indicated significant effects of carotenoids on C-reactive protein (CRP) (WMD: –0.54mg/L, 95% CI: –0.71, –0.37, P<0.001), and interleukin-6 (IL-6) (WMD: –0.54 pg/mL, 95% CI: –1.01, –0.06, P¼0.025), however the effect on tumor necrosis factor-alpha (TNF-a) was not significant (WMD: –0.97 pg/ml, 95% CI: –1.98, 0.03, P¼0.0.059). For the individual carotenoids, astaxanthin, (WMD: –0.30 mg/L, 95% CI: –0.51, –0.09, P¼0.005), lutein/zeaxanthin (WMD: –0.30 mg/L, 95% CI: –0.45, –0.15, P<0.001), and b-cryptoxanthin (WMD: –0.35 mg/L, 95% CI: –0.54, –0.15, P<0.001) significantly decreased CRP level. Also, only lycopene (WMD: –1.08 pg/ml, 95%CI: –2.03, –0.12, P¼0.027) led to a significant decrease in IL-6. The overall results supported possible protective effects of carotenoids on inflammatory biomarkers.

Actions (login required)

View Item